Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression
Lucia Casadei(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Raphael E. Pollock(The Ohio State University), Michele Guescini(University of Urbino), Federica Calore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), James L. Chen(Mayo Clinic), Raleigh D. Kladney(Washington University in St. Louis), Chad J. Creighton(Baylor College of Medicine), Dina Lev(Assuta Medical Center), Pierluigi Gasparini(The Ohio State University), Danielle Braggio(Ono Pharmaceutical (United States)), Kara Batte(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Abeba Zewdu(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Carlo M. Croce(The Ohio State University), Gonzalo Lopez(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Paolo Fadda(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Gustavo Leone(NanoAffix Science (United States)), O. Hans Iwenofu(The Ohio State University Wexner Medical Center), Kate Lynn J. Bill(The Ohio State University Wexner Medical Center), Francesca Lovat(Cancer Genetics (United States))
Cited by 199
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k